Thursday, April 25, 2019 7:29:13 PM
The Army contract ended on a bad note. KBLB was supposed to make 2 deliveries. The 1st delivery was for a few sample swatches. That delivery was late by about a year and half. So it took them over 2 years to make a few sample swatches. The 2nd delivery was for 200 lbs of custom spider silk, It was due last Sept. KBLB never made the 2nd delivery. KBLB asked for an extension, but never received it. It looks like the relationship between KBLB and the Army is over.
It took KBLB 5 years to get into Vietnam. And when I mean get into Vietnam, I mean to get a business license. It took them almost another year to get some eggs into Vietnam, since Vietnam is (rightfully) worried about GM animals. The silkworms have been sitting in a Vietnamese government installation for the past 4 or 5 months. Vietnam has not allowed KBLB to mass produce yet. Vietnam will have to approve mass production, and that might take many months or years (if it ever happens).
There is no production in the U.S. Only research.
KBLB is extremely low on funding. Every year they have to dilute shares to pay the bills.
Notre Dame is supposed to get a cut of KBLB profits (since they are the original owners of the IP). KBLB owed them a good amount of money (from the Army contract) and wasn't paying them for quite some time. So ND basically took KBLB to task and threatened to remove the IP (which would have made KBLB worthless). KBLB couldn't pay them money (since they don't have any), so KBLB diluted more shares and gave them stock.
The latest PR re: Polartec stated that they had a partnership. That is all.
KBLB spends about $1.8 million per year and currently has NO income. As of the end of last year, KBLB has accumulated a deficit of almost $27 million.
There is a lot more, but I think you get the gist...
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM